News & Documents

Market & Portfolio Commentary - January 2023

20.02.2023

Financial markets got off to a very strong start in 2023 with positive returns across equities, sovereign bonds and credit. The positive sentiment was driven by declining natural gas and oil prices, a re opening of the Chinese economy and lower inflation in most developed ma rkets. Given these developments, the macro outlook has improved, in particular for the Asian and European economies. For example, consumer co nfidence in the Euro Area rose to an 11 month high in January. a The only negative for the month was that some macro data are pointing to a faster than expected slowdown in the US economy, as ISM readings showed that December was the first month since May 2020 that both the services and manufacturing components were in contractionary territory.


European Sub Investment Grade Highlights
The Credit Suisse Western European Leveraged Loan Index return, hedged to Euro, was at 2 73 Defensives were 2 55 and cyclicals 2 91 in January CCCs returned 4 21 single Bs 3 01 and BBs 1 93 As at the end of January, the 3 year discount margin on the index was 581 bps The Credit Suisse Western European High Yield Index, hedged to Euro, returned 3 14 in January 2023.Primary levels started the year below 2022 average with 2 7 Bn loan and 1 Bn HY issuance The average Term Loan (“ B spread was 455 bps with a yield to maturity of 8 These included Restaurant Brands Iberia which priced and upsized a 310 m non fungible TL add on to fund M&A, Inetum which placed a 344 m fungible loan (upsized from 100 150 m) to refinance TLA held by banks and Verisure which completed the issuance of 450 m 5 yr SSN (upsized from 350 m initially targeted) We have also seen a handful of successful amend extend in January e g Altice France, Nord Anglia Education, SafetyKleen and PortAventura as issuers continue focusing on liability management Demand was generally strong across the board with most issuers upsizing deals.


Portfolio Commentary
January was a fairly active month on the trading side, both across the performing credit sleeve and the credit opportunities sleeve On the performing credit side, we added to a position in a pharmaceutical company at 97 25 and a spread of E+ 525 We also initiated a position in a French care home operator, and we swapped out of the loans of a telecom company and into the short dated fixed rate bonds that were trading c 2 5 points lower With the High Yield market reopening, we believe these bonds could be targeted for a refinancing by the company. In the credit opportunities sleeve, we added to a position in a UK holiday operator in the low 90 s as news came out that banks were willing to extend their Revolving Credit Facility, which is a first step of a larger refinancing exercise We exited a position in a US medical transport company as the combination of wage inflation and top line pressure from new regulations means a recovery will take a lot longer than originally expected We also added a few more positions to our CLO BB positions in the mid 80 s and we initiated a position in a gym operator. Across the entire portfolio, as of January month end, the weighted average market price was 86 4 trading at a yield of 18 1 hedged) 19 8 %%(GBP hedged), and delivering a 11 7 hedged) 13 4 %%(GBP hedged) running cash yield With the market rally we saw in January, the weighted average market price was up from 83 6 at the beginning of January However, this is still well below the average price of 96 5 on 1 January 2022 on the portfolio Floating rate instruments comprised 84 4 of the portfolio while 73 3 was invested in senior secured assets The portfolio had a cash position of 0 2 %%(including leverage) at the end of the month Base rates continue to move up with 3 M Euribor ending January at c 2 5 %%(vs 0 5 a year earlier) and O/N SONIA at 3 4 %%(vs 0 4 a year earlier) Both the ECB and the Bank of England hiked base rates by a further 0 5 in the first days of February.


Commentary Sources:
a. Bloomberg
b. Deutsche Bank
c. Credit Suisse
d. LCD February 2023

Important disclaimer and terms of use

These written materials are not for release, publication or distribution, directly or indirectly, in or into the United States, Australia, Canada, South Africa or Japan or to "U.S. persons" as defined in Regulation S under the US Securities Act ("US Persons"). The information contained herein does not constitute or form part of any offer or solicitation to purchase or subscribe for securities in the United States, Australia, Canada, South Africa or Japan or any other jurisdiction where to do so might constitute a violation of the relevant laws or regulations of such jurisdiction. The Company has not been and will not be registered under the US Investment Company Act of 1940, as amended (the "Investment Company Act") and, as such, holders of the Company’s securities will not be entitled to the benefits of the Investment Company Act. The securities discussed herein have not been and will not be registered under the US Securities Act of 1933, as amended (the "US Securities Act"), or with any securities regulatory authority of any state or other jurisdiction of the United States and may not be offered or sold in the United States or to, or for the account or benefit of, US Persons absent registration or an exemption from registration under the US Securities Act in a manner that would not require the Company to register under the Investment Company Act. No public offering of securities will be made in the United States. No securities may be offered or sold, directly or indirectly, into the United States or to US Persons absent registration or an exemption from registration under the US Securities Act and in a manner that would not require the Company to register under the Investment Company Act.

In addition, in the United Kingdom, these materials on this website are only being distributed to and are only directed at (i) persons who are outside the United Kingdom or (ii) to investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order") or (iii) high net worth entities, and other persons to whom they may lawfully be communicated, falling within Article 49(2)(a) to (e) of the Order (all such persons in (i), (ii) and (iii) above together being referred to as "relevant persons"). Securities to which the materials relate are only available to, and any invitation, offer or agreement to subscribe, purchase or otherwise acquire such securities will be engaged in only with, relevant persons. Any person who is not a relevant person should not act or rely on the materials or any of their contents.

Any communication on this website is only addressed to and is only directed at persons in any member state of the European Economic Area ("EEA Member State") where any required notification or registration for "marketing" as that term is defined in Article 4(1)(x) of Directive 2011/61/EU on alternative investment fund managers ("AIFMD") has been made and who are both:

  1. "qualified investors" in that Member State within the meaning of Article 2(e) of EU Prospectus Regulation (EU/2017/1129), as amended, including any relevant implementing measure in EEA Member State which has implemented the EU Prospectus Regulation; and
  2. "professional investors" in that EEA Member State within the meaning of Article 4(1)(ag) AIFMD.

A list of EEA Member States in which a notification or registration has been made for marketing to professional investors under AIFMD is available on request.

This website should not be accessed by persons in any EEA Member State who are "retail investors" within the meaning of Article 4(1)(aj) of the AIFMD ("retail investors").

Access to electronic versions of these materials is being made available on the webpage in good faith and for information purposes only. Making press announcements and other documents relating to any offering of securities available in electronic format does not constitute an offer to sell or the solicitation of an offer to buy or subscribe for securities, nor does it constitute a recommendation by any party to sell or buy securities.

By clicking on the "Accept" button, I confirm, represent, warrant and agree that:

I am not a US Person or located in the United States, Australia, Canada, South Africa or Japan or any other jurisdiction where to proceed to view the materials on this webpage would constitute a breach of securities law in that jurisdiction, and I confirm that I am permitted to view electronic versions of these materials; I will not forward, transmit or show the materials contained in this webpage to any US Person or person located in, or a resident of, the United States, Australia, Canada, South Africa or Japan or any other jurisdiction where it would be unlawful to do so; and I have read and understood the disclaimer set out above and will read carefully any additional disclaimers or important notices attaching to or forming part of the materials or information on this website. I understand that this may affect my rights, and I agree to be bound by their terms.

I am not a retail investor located in an EEA Member state.